Drug
pegcetacoplan
Marketed as EMPAVELI.
Generic name
pegcetacoplan
Brand names
EMPAVELI
First FDA approval
2021-05-14
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA215014 | EMPAVELI | 2021-05-14 | APELLIS PHARMS |
Manufacturers
APELLIS PHARMS
Frequently asked questions
When was pegcetacoplan FDA approved?
Earliest FDA approval on record: 2021-05-14.
What brand names are sold as pegcetacoplan?
EMPAVELI.
Sources
Appeal a pegcetacoplan denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com